RE-Stem specializes in clinically translatable cell therapies (stem cell & immune cells), stem cell-derived products, and cell banking, as well as supplying stem cells to other enterprises. RE-Stem has been built by an international team of seasoned scientists and expert executives.

2020年2月11日 · RE-Stem Biotech is a biotechnology firm engaged in the research and development of cell therapies targeting osteoarthritis, spinal cord injury and various cancers. Backed by state-of-the-art GMP facilities and an international team of world-leading scientists, doctors and directors, RE-Stem currently has a robust technology platform including ...

瑞思坦生物总部坐落于苏州市吴中经济开发区,专业从事SVF、免疫细胞、外泌体、组织工程、干细胞等生物技术的科研开发、临床转化、制备存储等一体化运作。

2020年2月11日 · RE-Stem is one of the earliest regenerative biotechnology companies in China to develop and apply human adipose stem cells. In 2012, RE-Stem introduced adipose stem cell technology into Chinese society and made tremendous progress in the application of safety and standardized production.

江蘇瑞思坦生物科技有限公司（RE-Stem Biotech）是由中國，美國著名醫學專家創辦的高端再生生物科技企業，專業從事自體脂肪幹細胞的研發及相關應用。

2025年1月10日 · Restem’s proprietary platforms leverage Umbilical Cord Lining Stem Cells (ULSCs) and Activated Natural Killer (NK) Cells to modulate immune responses and support tissue repair.

江苏瑞思坦生物科技有限公司 ( (RE-Stem Biotech)成立于2012年，是由中国、美国生物学家、医学家共同创办的高新技术企业。 公司专业从事干细胞、免疫细胞、细胞外泌体等生物技术的科研开发、临床实验及市场应用，在深圳、北京、赣州、昆明、武汉等地建设有符合国家标准的B+A生物实验室，实力打造“三位一体”的产业格局。 2020年9月，瑞思坦生物被安永...

Utilizing the body’s healing power to repair, regenerate and to recreate | Leading in biotechnology research and cell therapies Cell therapy lab expansion in hospitals and clinics Robust discovery...

Jiangsu RE-Stem Biotechnology Co., Ltd. (RE-Stem Biotech), a high-end regenerative biotechnology enterprise founded by renowned medical experts from China and the United States, specializes in the research and development of adipose-derived stem …

成立以来，瑞思坦生物坚持自主创新，专注自体细胞的研发与临床转化，创新细胞医疗技术，并致力于搭建覆盖全国的实验室及细胞库，为临床合作医院提供技术服务。 [1] 同时，瑞思坦生物 [1] 发起“孤舟宝贝救治计划” [3] 、“康民兴邦”惠民计划 [7] 等公益项目。 [1] 2022年1月，瑞思坦生物联合重庆渝北区人民政府共建“生物医学研发中心”、“生物医学临床转化中心”、“区域细胞制备中心”、“区域综合细胞库” [4]。 以“突破生命极限”为愿景，探索生命科学前沿，为人类寻找更有效的健康 …